Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture and marketing of the pharmaceutical products worldwide. It operates in two segments, Diabetes & Obesity care & Biopharm. It is based in Denmark, comes under Healthcare – Biotechnology sector & trades as “NVO” ticker at NYSE.
NVO is showing higher high clear impulse sequence in over the years. So, it expects to remain supported in 3, 7 or 11 swings at extreme areas in pullback. Currently, it favors correction in ((2)) of V of (I) before turning higher in ((3)) of V.
NVO – Monthly Elliott Wave Latest View: 
It placed wave ((I)) at $60.34 as Grand super cycle in 2015 & ((II)) at $30.89 low in 2016. Above there, it favors higher in (I) of ((III)). It favored ended I of (I) at $58.37 high & (II) at $41.23 low as 0.618 Fibonacci retracement. Above there, it extended higher in third wave extension, ended at $122.16 high. Wave IV finished at $95.02 low as slightly above 0.382 Fibonacci retracement. Currently, it favors higher in V as it already confirms higher high sequence.
NVO – Weekly Elliott Wave Latest View: 
In wave V, it placed (1) of ((1)) at $106.43 high & (2) at $100.89 low. Above there, it favored ended (3) at $139.05 high as third wave extended wave & (4) at $130.10 low. Finally, it ended (5) as ((1)) at $144.78 high & correcting in ((2)) in 7 or 11 swings towards $130.04 – $121.70 area before upside resumes in (1) of ((3)) of V. Alternatively, it may ended ((2)) at $131.17 low & favors higher in (1) of ((3)) of V or else, it may do double in ((2)) correction before turning higher in ((3)).
Elliottwave Forecast updates 1-hour charts four times a day & 4-hour charts once a day for all our 78 instruments. We do a daily live session where we guide our clients on the right side of the market. In addition, we have a chat room where our moderators will help you with any questions you have about what is happening in the market at the moment. You can try us for 14 days for only $9.99.
Back
